Navigation Links
Cell's split personality is a major discovery into neurological diseases
Date:5/7/2009

Researchers at the Universit de Montreal (UdeM) and the Montreal Neurological Institute (MNI), McGill University have discovered that cells which normally support nerve cell (neuron) survival also play an active and major role in the death of neurons in the eye. The findings, published this week in The Journal of Neuroscience, may lead to more streamlined therapies for a variety of acute and chronic neurological disorders, including glaucoma and retinal artery occlusion.

In many neurodegenerative diseases, a main factor that kills neurons is excessive levels of glutamate, the most abundant excitatory neurotransmitter in many regions of the central nervous system (CNS). Diseases that occur as a result of high glutamate levels include hypoxicischemic brain injury (stroke), trauma, seizures, various forms of dementia and neurodegeneration. For years, the main explanation for the toxic effects of glutamate is that it overexcites neuronal cells via activation of glutamate receptors and thereby kills them.

"The most interesting aspect of our study and the reason we are so excited is that the pathway leading to glutamate-induced nerve cell death involves another vital player namely, glial cells," says Dr. Adriana Di Polo, neuroscientist at the UdeM. "Through careful experimentation we now know that glutamate activates signaling pathways in glial cells that then lead to neuronal death."

Glial cells are the most abundant cell type in the nervous system and are traditionally thought of as 'partner' cells to nerve cells providing support, nutrients and an optimal environment. However, this study indicates that glial cells also have a more sinister side that allows them to induce or exacerbate neuronal death in pathological conditions.

"Neuronal cell death induced by glutamate is a key step in a large number of injury and disease settings and this study is important because it provides a road-map for the cellular and molecu
'/>"/>

Contact: Anita Kar
anita.kar@mcgill.ca
514-398-3376
McGill University
Source:Eurekalert

Page: 1 2

Related biology news :

1. ESF EURYI award winner aims to stop cancer cells reading their own DNA
2. Newly created cancer stem cells could aid breast cancer research
3. AIDS interferes with stem cells in the brain
4. Clemson scientists shed light on molecules in living cells
5. Social habits of cells may hold key to fighting diseases
6. UF scientists reveal how dietary restriction cleans cells
7. Human derived stem cells can repair rat hearts damaged by heart attack
8. Scientists identify embryonic stem cells by appearance alone
9. Cells united against cancer
10. Pittsburgh scientists identify human source of stem cells with potential to repair muscle
11. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... survey carried out in eight European countries ha...fectious disease pandemic could have a significant...s writing in the open access journal BMC Infectio...on school days and weekends/holidays, finding that... Hens, from Hasselt and Antwerp University, Belgiu...
(Date:11/26/2009)...RSA (methicillin-resistant Staphylococcus Aureus ...ihilation as low-temperature plasma prototype devi... and unfailing bactericidal cocktails. , Two pro...ent disinfection of healthy skin (e.g. hands and f... can pose a lethal threat; and another to shoot ba...
(Date:11/25/2009)...thens, Ga. Bacteria don,t have easy lives. In add... bugs, they have natural enemies called bacterioph... every two days. , Still, bacteria and another ...overed in extreme environments such as deep-sea vo... because they have a built-in defense system that ...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 1Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 2Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 3Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin 49327 1Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin 49327 2Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin 49327 3EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health 4613 1EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health 4613 2EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health 4613 3
... 23, 2007, President Bush stated that, in order to... increase the supply of alternative fuels, by sett...on gallons of renewable and alternative fuels in 2...l refiner subsidy promised in the 2008 Farm Bill a... growers are putting energy needs ahead of environ...
...th breast cancer today are candidates for lumpecto...ast tissue. Results of a UC Davis study, however, ... the same breast are treated with a second lumpect...tment recommendations and cutting the number of ye...rised to find that so many women in our study alm...
...r undertaken of the upper U.S. Gulf Coast suggests...rs could flood large swaths of wetlands this centu...In terms of sea-level increases and river sediment... a time when bays will face conditions they last s...ears ago," said lead researcher John Anderson, the...
Other Biology News:Mandate for biofuels production requires science-based policy and global perspective 2Second lumpectomy for breast cancer reduces survival rates 2Bays on US Gulf Coast vulnerable to flooding 2
(Date:11/30/2009)... , BRIARCLIFF MANOR, N.Y., Nov. 30 /PRNew...y guidance document for the publication of company...line today by the British Medical Journal (BMJ). "...on of the importance of providing support and guid...cation of study results in the peer-reviewed medic...
(Date:11/30/2009)..., CHICAGO, Nov. 30 Dr. Jessica ...ge Washington University Medical Center in Washing... Breast-Specific Gamma Imaging (BSGI) in clinical ...agnosis of breast cancer today at the annual meeti...SNA). ,, "The purpose of the exhibit was to dem...
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCa...day it has completed enrollment in the Phase II cl...2008/2009 recommended strains) VLP vaccine candida...er adults). This randomized, double-blind, active...ility and immunogenicity of two different doses (1...
(Date:11/30/2009)... PDS, a leader in providing sma...nity, announces Pajama Pathology®, evolutioniz... same ‘gold standard’ software used by...orld, but on a ‘cost per slide’ basis....RWEB) November 30, 2009 -- PDS has announced anoth...
Breaking Biology Technology:ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3
... Increased 5-Year Survival Data for Responding Pat...rporated (OTC Bulletin Board: GNTA) announced that...d and Drug Administration (FDA) for its,New Drug A...um) Injection,plus chemotherapy for patients with ...a (CLL). The submission is based on new informatio...
...June 6 DURECT Corporation,(Nasdaq: DRRX ) announ...at,three upcoming life sciences conferences in New...gy and Medical Technology Conference on Thursd...,s Pain Roundtable Conference, on Monday, June 23r... Healthcare Conference on Thursday, June 26th at ...
...une 6 InterMune, Inc.,(Nasdaq: ITMN ) today anno...,Chief Financial Officer of InterMune, will presen...Healthcare Conference in Dana Point, Calif. on,Jun...Hodgman will also,present at the Seventh Annual Ne...hnology Conference in New York on June 12, 2008 at...
Other Biology Technology:Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia 2Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia 3Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia 4InterMune to Present at Goldman Sachs Healthcare and Needham & Co. Biotechnology and Medical Technology Conferences 2
Rat Anti-p19ARF Monoclonal Antibody, Unconjugated, Clone 5-C3-1 from Upstate
EDTA, tetrasodium salt from GE Healthcare, formerly Amersham Biosciences
Tracker Datamatrix RS-1* from Micronic BV
GeneAmplimer HIV-1 Control Reagents from Applied Biosystems
Biology Products: